Steroid Treatment for Frontal Fibrosing Alopecia
For frontal fibrosing alopecia with active disease (perifollicular erythema, symptoms), use intralesional triamcinolone acetonide as the primary steroid intervention, which achieves symptom reduction and hairline stabilization in 97% of patients. 1
Treatment Algorithm
First-Line Steroid Approach
Intralesional corticosteroids are the most effective steroid modality for FFA based on the strongest evidence:
- Intralesional triamcinolone acetonide achieved disease stabilization in 97% of treated patients in the largest retrospective cohort (62 patients) 1
- 31% of patients maintained remission for 6 months to 6 years after stopping treatment 1
- Pooled data shows 88% positive response rate (181/204 patients) across multiple studies 2
Topical Steroids: Limited Role
Topical clobetasol 0.05% solution can be used but shows modest efficacy:
- In one comparative study, topical clobetasol showed no significant improvement compared to no treatment in patients with stable disease 3
- However, topical corticosteroids combined with minoxidil arrested hair loss in early-stage disease with perifollicular erythema 4
- Use topical steroids only in early inflammatory phase when perifollicular erythema is present 4
Systemic Corticosteroids: Avoid
Oral prednisone is NOT recommended as it only temporarily delays rapid hair loss and is seldom used 2. Reserve systemic steroids only for rapidly progressive disease as a temporizing measure 3.
Critical Treatment Principles
Timing Matters
- Early intervention is crucial because hair loss is permanent once scarring occurs 2, 5
- Treatment should target the active inflammatory phase (presence of perifollicular erythema, symptoms like itching/burning) 4
- 72% of patients initially present with stable disease where treatment may be futile 3
Identifying Active Disease
Look for these signs indicating treatment candidacy:
- Perifollicular erythema (present in 73% of cases) 1
- Perifollicular hyperkeratosis (31% of cases) 1
- Symptoms: itching, pain, or burning (65% of patients) 1
- Progressive hairline recession on serial examination
Common Pitfalls
Treating stable disease: 13 of 18 patients in one study had stable disease at presentation with no benefit from any intervention 3. Document baseline hairline position and reassess for progression before committing to treatment.
Using steroids as monotherapy: The most recent consensus (2026) recommends multimodal therapy starting with oral dutasteride plus topical/intralesional agents, not steroids alone 5. Intralesional steroids work best as part of combination therapy.
Expecting hair regrowth: The goal is disease stabilization, not regrowth, due to the scarring nature of FFA 6. Set realistic patient expectations.
Delayed treatment: Because follicular stem cells are permanently lost, waiting to treat active inflammation allows irreversible damage 5.
Practical Steroid Regimen
When using intralesional triamcinolone acetonide:
- Inject into areas of active disease (perifollicular erythema)
- Target the advancing hairline border
- Typical concentration: triamcinolone acetonide 10 mg/mL
- Frequency: monthly injections during active phase
- Monitor for stabilization at 3-6 month intervals 1
The evidence strongly favors intralesional over topical or systemic steroids, with intralesional triamcinolone showing the highest success rate for halting disease progression when used in early, active disease 1, 2.